Community Healthcare Trust (CHCT) Q4 2025: Capital Recycling Drives $12.1M Gain, Pipeline Anchors 9%+ Returns

CHCT’s disciplined capital recycling and selective acquisitions delivered a $12.1 million gain, while a robust pipeline supports high single-digit returns and portfolio diversification. Management’s focus on asset rotation, maintaining modest leverage, and extending lease terms positions the REIT for stable cash flow and embedded growth in 2026. Investors should watch for execution on redevelopment projects and the closing of the behavioral hospital transaction to further unlock value.

Summary

  • Capital Rotation Tailwind: Asset sales and 1031 exchanges are enabling accretive reinvestment and portfolio de-risking.
  • Pipeline Anchors Growth: Signed deals and redevelopment projects provide clear visibility into high-return deployments.
  • Leverage Discipline Maintained: No new equity issued as management prioritizes balance sheet strength and dividend growth.

Performance Analysis

Community Healthcare Trust’s Q4 2025 results highlight a strategic shift toward capital recycling and portfolio optimization. Total revenue grew 5.6% year over year, reflecting disciplined acquisition activity and occupancy gains, though quarter-over-quarter revenue dipped slightly due to asset dispositions. Occupancy improved to 90.6%, up 50 basis points sequentially, and the weighted average lease term extended to seven years, signaling improved cash flow visibility.

FFO, or funds from operations—a key REIT profitability metric—rose 4.6% year over year, with AFFO (adjusted funds from operations) up 2.1%. However, both metrics were down one cent per share sequentially, reflecting timing gaps from asset sales and acquisitions. Net gains from asset sales reached $12.1 million, with proceeds redeployed into higher-yielding properties, supporting both near-term returns and long-term diversification.

  • Expense Containment: Property operating and G&A expenses remained nearly flat year over year and quarter over quarter, underscoring cost discipline.
  • Interest Cost Relief: Interest expense declined slightly, benefiting from recent FOMC rate cuts and lower floating-rate debt costs.
  • Dividend Growth Continuity: The quarterly dividend was raised again, now annualizing to $1.91 per share, extending an unbroken streak since IPO.

CHCT’s ability to execute accretive recycling and maintain high occupancy while avoiding dilution through new equity issuance stands out in a capital-constrained environment. The company’s pipeline of signed acquisitions and redevelopment projects underpins steady growth into 2026.

Executive Commentary

"Our occupancy increased from 90.1 to 90.6% during the quarter, and our leasing team is very busy with renewals and new leasing activity. Our weighted average lease term increased from 6.7 to 7 years. We have three properties that are undergoing redevelopment or significant renovations with long-term tenants in place when the renovations or redevelopment are complete."

Dave Dupuy, Chief Executive Officer

"Total revenue grew from $29.3 million in the fourth quarter of 2024 to $30.9 million in the fourth quarter of 2025, representing 5.6% annual growth over the same period last year. ... Interest expense decreased slightly by approximately $100,000 quarter over quarter to $7 million in the fourth quarter of 2025, due primarily to recent FOMC interest rate cuts and the resulting lower floating rates on our revolving credit facility."

Bill Monroe, Chief Financial Officer

Strategic Positioning

1. Capital Recycling as a Core Lever

CHCT’s capital recycling program—selling lower-yield assets and reinvesting proceeds through 1031 like-kind exchanges—has become a central strategy. The Q4 sale of an inpatient rehab facility at a 7.9% cap rate, with proceeds redeployed into a new facility at a 9.3% yield, exemplifies this approach. This not only boosts returns but also reduces tenant concentration risk, enhancing portfolio resilience.

2. Embedded Pipeline and Redevelopment Visibility

Five properties are under definitive purchase agreements for a total of $122.5 million in expected investment, with anticipated returns between 9.1% and 9.75%. Additionally, three properties are undergoing redevelopment, with completion and rent commencement slated for mid to late 2026. These projects provide embedded NOI (net operating income) growth, functioning as future acquisitions with long-term tenants already secured.

3. Balance Sheet and Leverage Management

Management reiterated its intent to avoid raising equity at current share prices, relying instead on asset sales and revolver capacity to fund acquisitions. This approach maintains modest leverage while still enabling growth, a critical discipline in today’s cost of capital environment.

4. Leasing and Occupancy Execution

Occupancy gains and lease term extensions reflect strong leasing execution, even as some terminations created short-term vacancies. Management expects occupancy to remain in the low 90s for the next few quarters, with incremental gains likely in the second half of 2026 as new leases and redevelopments come online.

Key Considerations

CHCT’s quarter was defined by operational discipline and strategic asset rotation, with management emphasizing risk mitigation and embedded growth. The company’s approach to capital allocation and tenant diversification is central to its forward trajectory.

Key Considerations:

  • Tenant Transition Watchpoint: The pending sale and lease transfer of six geriatric behavioral hospitals is progressing, but timing remains uncertain and could impact near-term cash flow.
  • Selective Acquisition Discipline: Management continues to avoid issuing equity at current share prices, prioritizing only the highest-return and lowest-risk acquisitions.
  • Dividend Growth Commitment: The quarterly dividend increase, despite flat sequential AFFO, signals confidence in cash flow stability and future growth.
  • Cap Rate Spread Opportunity: The ability to sell at sub-8% cap rates and buy at 9%+ supports accretive growth and portfolio yield expansion.

Risks

Execution risk remains elevated around the behavioral hospital operator transaction, as delays or a failed closing could impact rent collections and portfolio stability. Timing mismatches between dispositions and acquisitions may cause temporary dilution or leverage spikes. Broader healthcare real estate market volatility, tenant credit events, and regulatory shifts also present ongoing risks, especially as CHCT’s business model relies on stable rent rolls and tenant performance.

Forward Outlook

For Q1 and Q2 2026, CHCT expects:

  • Occupancy to remain in the low 90% range, with incremental gains possible in the second half of the year as redevelopments and new leases become economic.
  • Continued capital recycling activity, with at least one pipeline property expected to close in Q1 and additional closings in the second half of 2026 and into 2027.

For full-year 2026, management highlighted:

  • Embedded NOI growth from redevelopment projects coming online in mid and late 2026.
  • Selective acquisitions with expected returns above 9% anchoring portfolio yield expansion.

Management emphasized that balance sheet discipline and dividend growth remain priorities, with no plans to issue equity unless share price conditions improve.

Takeaways

CHCT’s quarter demonstrates the power of disciplined asset rotation and pipeline visibility, with capital recycling fueling both returns and diversification. The REIT’s focus on tenant quality, lease term extension, and risk-managed acquisition activity positions it well for 2026, though investors must monitor execution on key transactions and redevelopment timelines.

  • Capital Recycling Drives Value: Accretive dispositions and reinvestments are enhancing portfolio yield and reducing tenant concentration risk.
  • Pipeline Underpins Embedded Growth: Signed deals and redevelopment projects provide clear visibility into future cash flow expansion.
  • Execution on Key Transactions Critical: The behavioral hospital operator transition and timing of pipeline closings will be major watchpoints for investors in the coming quarters.

Conclusion

Community Healthcare Trust’s Q4 2025 results underscore a disciplined, risk-aware approach to growth, with capital recycling and embedded pipeline projects providing a foundation for yield expansion and dividend growth. Investors should focus on execution risk in key transactions and the realization of redevelopment returns as the primary drivers of forward performance.

Industry Read-Through

CHCT’s ability to sell at sub-8% cap rates and buy at 9%+ highlights a persistent spread opportunity in healthcare real estate, especially for operators willing to rotate capital and manage tenant concentration. The focus on redevelopment and long-term lease structuring reflects a broader industry pivot toward embedded growth and risk mitigation amid a higher cost of capital. Other healthcare REITs and net lease investors should note the shift away from equity issuance and the emphasis on balance sheet discipline, as well as the operational complexity of tenant transitions in specialty healthcare segments. The market’s appetite for stabilized, high-yield assets remains robust, but execution on redevelopment and tenant transitions will increasingly separate outperformers from laggards.